Kymanox at the PDA/FDA Joint Regulatory Conference 2026
14 – 16 September 2026 | Washington, DC
Kymanox will be attending the PDA/FDA Joint Regulatory Conference 2026, a leading forum for dialogue between global regulators and pharmaceutical industry professionals. The conference will take place in Washington, DC and brings together experts focused on advancing quality systems, strengthening compliance, and protecting patients across the product lifecycle.
Throughout the event, members of the Kymanox team will be onsite engaging with peers on current Good Manufacturing Practice (CGMP), regulatory expectations, and evolving approaches to quality and compliance. The conference highlights practical strategies, real-world case studies, and regulatory perspectives that support sustainable compliance and operational excellence.
PDA provides a valuable environment for technical exchange and collaboration, with a strong focus on aligning industry and regulatory priorities and advancing best practices across pharmaceutical development and manufacturing.
📍 Connect with us in Washington, DC
We welcome the opportunity to connect during the conference to discuss quality systems, regulatory strategy, and the evolving compliance landscape across pharmaceutical and biotech organizations.
